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Background: Around 70% of those living with HIV in need of treatment accessed antiretroviral therapy (ART) in
Zambia by 2009. However, sustaining high levels of adherence to ART is a challenge. This study aimed to identify
the predictive factors associated with ART adherence during the early months of treatment in rural Zambia.
Methods: This is a field based observational longitudinal study in Mumbwa district, which is located 150 km west
of Lusaka, the capital of Zambia. Treatment naive patients aged over 15 years, who initiated treatment during
September-November 2010, were enrolled. Patients were interviewed at the initiation and six weeks later. The
treatment adherence was measured according to self-reporting by the patients. Multiple logistic regression analysis
was performed to identify the predictive factors associated with the adherence.
Results: Of 157 patients, 59.9% were fully adherent to the treatment six weeks after starting ART. According to the
multivariable analysis, full adherence was associated with being female [Adjusted Odds Ratio (AOR), 3.3; 95%
Confidence interval (CI), 1.2-8.9], having a spouse who were also on ART (AOR, 4.4; 95% CI, 1.5-13.1), and experience
of food insufficiency in the previous 30 days (AOR, 5.0; 95% CI, 1.8-13.8). Some of the most common reasons for
missed doses were long distance to health facilities (n = 21, 53.8%), food insufficiency (n = 20, 51.3%), and being
busy with other activities such as work (n = 15, 38.5%).
Conclusions: The treatment adherence continues to be a significant challenge in rural Zambia. Social supports
from spouses and people on ART could facilitate their treatment adherence. This is likely to require attention by
ART services in the future, focusing on different social influences on male and female in rural Zambia. In addition,
poverty reduction strategies may help to reinforce adherence to ART and could mitigate the influence of HIV
infection for poor patients and those who fall into poverty after starting ART.Background
Sub-Saharan Africa contains nearly 70% of the world’s
HIV infections. In 2009, the average number of people
living with HIV (PLWH) reached 22.5 million [1-3].
Zambia is one of the most severely affected countries in
the region. Since Zambia’s first reported AIDS diagnosis
in 1984, the proportion of PLWH has rapidly increased,* Correspondence: yurippe1006@hotmail.com
1Department of Infection Control and Prevention, Graduate School of
Nursing, Nagoya City University, Kawasumi 1, Mizuho-ku, Nagoya-shi, Aichi
467-8601, Japan
Full list of author information is available at the end of the article
© 2012 Sasaki et al.; licensee BioMed Central L
Commons Attribution License (http://creativec
reproduction in any medium, provided the orpeaking in the mid-1990s at about 16% and reaching as
high as 25% in some urban areas [4,5]. The Zambia HIV
epidemic has moderately stabilized over the last 15 years
with a very modest decline after the initial peak in preva-
lence [6]. Although the rate of new HIV infections has
decreased, the total number of PLWH continues to rise.
An estimated average of 980,000 (890,000–1,100,000)
people in a population of 12.9 million have been infected
with HIV in Zambia [6,7]. Adults aged 15–49 had an HIV
prevalence of 13.5% in 2009, which was the 6th highest in
Sub-Saharan countries [2].td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Description of study sample.
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Zambia became operational in 2002. One of its key pri-
orities is the provision of care, treatment and support
to PLWH [3]. In 2004, the Ministry of Health (MoH)
in Zambia offered antiretroviral therapy (ART) at four
clinics in Lusaka, the capital of Zambia. The government
declared that the entire ART service package would be
provided free of charge in the public sector, with a goal
of universal access to HIV care and treatment [8].
As more than half of the population lives in rural areas
where there is poor access to health services [9], the
MoH aimed to develop approaches to expand services
by strengthening the existing public health care system
and expressed its intention to expand HIV testing and
treatment facilities to all districts and as close to house-
holds as possible [10]. With this effort, 283,863 (68%)
people out of an estimated total population of 416,533
who were in need of ART received it at 447 health fa-
cility sites throughout the country by 2009, and the
number of sites is being expanded further [6]. While
achievements have been remarkable, the universal cove-
rage and retaining the patients on ART remain as chal-
lenges. Studies showed that 59.5% of patients in Zambia’s
southern province throughout a period of 15–723 days
(a median follow-up of 275 days) and 62.9% of patients in
Lusaka over the first 12 months (a median follow-up of
15.7 months from 12 months onwards) were adherent to
ART[11,12].
Some reports also have revealed the factors associated
with adherence in both urban and rural settings [8,12-18].
The common reasons raised by patients on ART for poor
adherence in several qualitative studies included demo-
graphic and physical health factors (e.g. insufficient food
and side effects) as well as interpersonal factors (e.g. lack
of support) [15,16,18]. Other barriers were patients’ men-
tal health factors (e.g. fear of stigma/disclosure and pre-
sence of depression/ hopelessness) [16,18].
Such qualitative studies in Zambia generate information
from the respondent’s perspective that may facilitate cul-
turally appropriate and effective interventions. However,
few quantitative studies have investigated associations be-
tween the treatment adherence and factors identified in
these qualitative studies. In addition, there is a paucity of
studies which have investigated factors related to the treat-
ment adherence during the early months of treatment.
Since most complications including deaths occur within
early period of treatment [8], optimizing adherence during
this stage is important for ensuring long-term immuno-
logical and virological treatment success [19,20].
Thus, the objective of this study was to identify pre-
dictive factors associated with ART adherence during the
early months of treatment in rural Zambia so as to pro-
pose possible interventions for future treatment strategies
in this region.Methods
Study design and study site
A field based observational longitudinal study was con-
ducted in Mumbwa district, which is located 150 km
west of Lusaka. There were one district hospital and 27
rural health centers in Mumbwa during the study period.
Among the health facilities, ART services were available
at the district hospital, and at eight rural health centers.
Study population
During the study period, all patients who met the cri-
teria of treatment initiation according to the Zambia
HIV National Guidelines and visited the district hospital
or one of the eight rural health centers were invited to
participate in the study. The eligible population for this
study comprised patients who 1) were aged 16 and over;
2) were ART-naïve and newly registered for ART services
from September to November 2010; and 3) agreed to give
informed consent. The exclusion criteria included patients
who were too ill to be interviewed. Patients were inter-
viewed at the initiation of treatment as a baseline and six
weeks later as a follow-up (Figure 1).
Study tools
Structured questionnaires for both baseline and follow-
up interviews were developed, following the generic
tools developed by World Health Organization (WHO)
[21] and the AIDS clinical trial group (ACTG) adher-
ence follow-up questionnaires [22]. The questionnaires
were first developed in English. After being translated into
Nyanja (dominant regional language), these were back-
translated to English to ensure its clarity and consistency.
The questionnaires covered respondents’ sociodemogra-
phic characteristics, ART adherence, disclosure status,
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HIV/AIDS stage [23], weight, CD4 cell count, and Tuber-
culosis (TB) status were extracted from individual me-
dical records.
In this study, full adherence to ART was defined as
when a patient had never skipped prescribed drugs and
had followed time restrictions during the previous
four days before the interview. Scores for internalized
AIDS-related stigma and cognitive/affective depression
were measured using scales developed and validated
by Kalichman [24]. To simplify the administration, the
items were responded to dichotomously, 1=agree and
0=disagree; and scale scores represent the sum total of
endorsed stigma items, range 0–6. The cognitive/affective
depression subscale is an 11-item measure that assesses
symptoms of depression over the previous seven days,
0=no days, 1=1-2 days, 2=3-4 days, and 3= 5–7 days. The
median of each scale score was used as the cutoff point
between patients who had self-stigma or depressive symp-
toms and who did not.
Food insufficiency was measured by using one closed-
ended question following the Sociodemographic Module
of the Client Instrument developed by WHO as a gen-
eric tool for operational research on HIV testing, treat-
ment and prevention [21]. Patients were asked to recall
the frequency with which there was not enough food in
the month prior to interview: never, sometimes, often,
or almost always. A similar single question assessment
of food insufficiency has been validated in previous stu-
dies [25,26].Data collection
Before the commencement of the study, a three-day
training course on research protocols, administration of
questionnaires, and ethics was conducted for eight in-
terviewers. Then field surveys were carried out from
September 2010 to March 2011.Data analysis
Data obtained from the questionnaire surveys were ana-
lyzed with SPSS version 19 statistical software. Baseline
characteristics of participants were compared between
patients who were adherent to ART six weeks after start-
ing the treatment and those who were not, using
Pearson’s chi-square test and Fisher’s exact test. Multiple
logistic regression analysis was performed to identify the
predictive factors associated with ART adherence. The
variables of which the associated p value level was less
than 0.1 were entered into the multiple logistic regres-
sion model. If the variable was highly correlated with the
other variable, one of them was removed from the
model. An adjusted odds ratio (AOR) was calculated for
the levels of the other factors included in the model.Ethical considerations
This study was approved by the Research Ethics Com-
mittee of the University of Tokyo, the Biomedical Re-
search Ethics Committee of the University of Zambia,
and the Institutional Ethics Committee of the National
Center for Global Health and Medicine (NCGM). Writ-
ten informed consent was obtained from respondents at
the beginning of the interview, after the study was ex-
plained to them. They were informed that participation in
the study was voluntary.
Results
Description of study sample
During the field research, 241 patients who were newly
registered for ART services were enrolled and inter-
viewed enrolled and interviewed (Figure 1). After the
baseline survey, 84 could not be interviewed six weeks
later because six patients had passed away, two patients
referred to the other health facilities, and 76 patients did
not answer questions completely at the baseline or did
not appear on the appointment date and we could not
reach their contact address. The sociodemographic,
physical and mental health of these patients did not dif-
fer from the patients included in the analysis except for
the required time to reach the health facilities (Table 1).
Therefore, data from the remaining 157 were used for
statistical analysis.
Demographic characteristics of patients on ART
Seventy-four (47.1%) of patients visited the district hos-
pital for ART services (Table 2). The median age was 35
years old (range: 18–68), 94 (59.9%) were female, and 105
(66.9%) were married. Around half of patients (n = 77,
49.4%) had not completed the standard primary education
of seven years and 107 (68.2%) were farmers. Sixty-one
(38.9%) reported experiences of food insufficiency in the
previous 30 days.
With regard to the transportation, 127 (80.9%) did not
need to pay the transportation fee to access the district
hospital or rural health centers. Over half of patients
(n = 80, 51%) travelled to the health facility on foot and
85 (54.8%) required more than one hour for this journey.
The general physical and mental health of patients was
also surveyed. One hundred thirty-eight (87.9%) had a
functional status of being able to work, and 11 (7.1%)
were smear-positive for TB. Over half of patients had
self-stigma (n = 87, 56.5%) and were depressed (n = 92,
58.6%). In addition, 89 (85.6%) disclosed their HIV status
to their spouse, and 36 (29.3%) spouses were also recei-
ving ART (Table 3).
Status of ART adherence
Among 157 patients on ART who were included in this
study, 94 (59.9%) were fully adherent and 63 (40.1%)





Mumbwa District Hospital 42 (50.0) 74 (47.1) 0.671
Rural Health Centers 42 (50.0) 83 (52.9)
Age
<35 years old 40 (47.6) 70 (46.1) 0.817
≥35 years old 44 (52.4) 82 (53.9)
Sex
Female 43 (51.2) 94 (59.9) 0.195
Male 41 (48.8) 63 (40.1)
Education
No or primary incomplete 39 (46.4) 77 (49.4) 0.665
Primary complete or more 45 (53.6) 79 (50.6)
Marital status
Married 46 (55.4) 105 (66.9) 0.080
Not married 37 (44.6) 52 (33.1)
Occupation
Agriculture 49 (58.3) 107 (68.2) 0.128
Others 35 (41.7) 50 (31.8)
Transportation
On foot 50 (59.5) 80 (51.0) 0.204
Others 34 (40.5) 77 (49.0)
Time required for transportation to health facilities by above method
Within one hour 51 (61.4) 70 (45.2) 0.017
More than one hour 32 (38.6) 85 (54.8)
Transportation cost
Zero 72 (85.7) 127 (80.9) 0.347
More than zero 12 (14.3) 30 (19.1)
Lack of food during the past 30 days
Yes 27 (32.5) 61 (38.9) 0.334
No 56 (67.5) 96 (61.1)
Functional status
Working 69 (85.2) 138 (87.9) 0.556
Ambulant or bed lid 12 (14.8) 19 (12.1)
Tuberculosis
Positive 9 (11.1) 11 (7.1) 0.286
Negative or not sure 72 (88.9) 145 (92.9)
Self-stigma at baseline
Yes (Score: 2-6) 52 (62.7) 87 (56.5) 0.359
No (Score: 0-1) 31 (37.3) 67 (43.5)
Depressive symptoms at baseline
Yes (Score: 13-33) 50 (62.5) 92 (58.6) 0.562
No (Score: 0-12) 30 (37.5) 65 (41.4)
Pearson’s chi-square test.
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Table 2 Sociodemographic, physical mental health characteristics of patients who were adherent and non-adherent to
ART
Total Not full adherence Full adherence
(n=157) (n=63) (n=94) p-value
n(%) n(%) n(%)
Site
Mumbwa District Hospital 74 (47.1) 32 (50.8) 42 (44.7) 0.452
Rural Health Centers 83 (52.9) 31 (49.2) 52 (55.3)
Age
<35 years old 70 (46.1) 25 (41.7) 45 (48.9) 0.381
≥35 years old 82 (53.9) 35 (58.3) 47 (51.1)
Sex
Female 94 (59.9) 30 (47.6) 64 (68.1) 0.010*
Male 63 (40.1) 33 (52.4) 30 (31.9)
Education
No or primary incomplete 77 (49.4) 30 (48.4) 47 (50.0) 0.844
Primary complete or more 79 (50.6) 32 (51.6) 47 (50.0)
Marital status
Married 105 (66.9) 45 (71.4) 60 (63.8) 0.321
Not married 52 (3.1) 18 (28.6) 34 (36.2)
Occupation
Agriculture 107 (68.2) 26 (41.3) 24 (25.5) 0.038*
Others 50 (31.8) 37 (58.7) 70 (74.5)
Transportation
On foot 80 (51.0) 36 (57.1) 44 (48.8) 0.204
Others 77 (49.0) 27 (42.9) 50 (53.2)
Time required for transportation to health facilities by above method
Within one hour 70 (45.2) 29 (46.8) 41 (44.1) 0.742
More than one hour 85 (54.8) 33 (53.2) 52 (55.9)
Transportation cost
Zero 127 (80.9) 50 (79.4) 77 (81.9) 0.690
More than zero 30 (19.1) 13 (20.6) 17 (18.1)
Lack of food during the past 30 days
Yes 61 (38.9) 14 (22.2) 47 (50.0) <0.001***
No 96 (61.1) 49 (77.8) 47 (50.0)
Knowing HIV status
Within 30 days 65 (41.7) 37 (39.8) 28 (44.4) 0.562
More than 30 days 91 (58.3) 56 (60.2) 35 (55.6)
Functional status
Working 138 (87.9) 58 (92.1) 80 (85.1) 0.190
Ambulant or bed lid 19 (12.1) 5 (7.9) 14 (14.9)
Tuberculosis
Positive 11 (7.1) 5 (7.9) 6 (6.5) 0.722
Negative or not sure 145 (92.9) 58 (92.1) 87 (93.5)
Pearson’s chi-square test; *p<0.05;***p<0.001.
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Table 3 Interpersonal characteristics of patients who were adherent and non-adherent to ART
Total Not full adherence Full adherence
(n=157) (n=63) (n=94) p-value
n(%) n(%) n(%)
Disclose to First wife/husband if married
Yes 89 (85.6) 35 (77.8) 54 (91.5) 0.048 a*
No 15 (14.4) 10 (22.2) 5 (8.5)
First additional sexual partner
Yes 13 (59.1) 7 (63.6) 6 (54.5) 1.000 b
No 9 (40.9) 4 (36.4) 5 (45.5)
People in community know my HIV status even though I did not tell them
Yes 48 (38.6) 21 (37.5) 27 (31.0) 0.424 a
No or unsure 95 (66.4) 35 (62.5) 60 (69.0)
First wife/husband’s HIV status if married (including divorced, separated,
widow/widower)
Positive 58 (44.6) 20 (37.7) 38 (49.4) 0.190 a
Negative or unsure 72 (55.4) 33 (62.3) 39 (50.6)
First wife/husband is (was) on ART (including divorced, separated,
widow/widower)
Yes 36 (29.3) 10 (20.0) 26 (35.6) 0.062 a
No or unsure 87 (70.7) 40 (80.0) 47 (64.4)
First additional sexual partner’s HIV status
Positive 0 0.0 0 0.0 0 0.0
Negative or unsure 21 (100.0) 10 (100.0) 11 (100.0)
First additional sexual partner is on ART
Yes 0 0.0 0 0.0 0 0.0
No or unsure 18 (100.0) 9 (100.0) 9 (100.0)
a: Pearson’s chi-square test; b: Fisher’s exact test; *p<0.05.
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starting ART.
Factors associated with full ART adherence
Bivariate analysis indicated that being female (p = 0.010),
disclosure to spouses (p = 0.048), and experiences of
food insufficiency in the previous 30 days (p < 0.001)
were positively associated with adherence to ART, but
being farmers (p = 0.038) were negatively associated
(Tables 2 & 3). Additionally, the proportion of patients
who were adherent to ART was likely to be higher amongTable 4 Multiple logistic regression analysis of factors affectin
Variable B
Gender (Females) 0.21
Experience of food insufficiency in the previous 30 days 0.30
Disclose HIV status to spouse 0.20
Spouse on ART 0.26
R2 0.28
B: Unstandardized coefficient; SE: Standard error; β: Standardized coefficient; p valu
Coefficient of determination. The variables of which the associated p value level wa
regression model.patients whose spouse was also receiving ART than pa-
tients whose spouse was not, although this was not statis-
tically significant (p = 0.062) (Table 3).
To identify the factors associated with full ART ad-
herence, multiple logistic regression analysis was perfor-
med. Full adherence was associated with being female
[AOR, 3.3; 95% Confidence interval (CI), 1.2 - 8.9], ha-
ving a spouse who were also receiving ART (AOR, 4.4;
95% CI, 1.5 - 13.1) and experience of food insufficiency
in the previous 30 days (AOR, 5.0; 95% CI, 1.8 - 13.8)
(Table 4).g adherence to ART (n=96)
SE β p AOR 95% CI
0.09 0.21 0.021* 3.26 1.20-8.90
0.09 0.31 0.002** 5.00 1.81-13.76
0.12 0.15 0.130 2.85 0.73-11.06
0.09 0.25 0.007** 4.44 1.50-13.12
e at <0.05* & <0.01**; A0R: Adjusted odds ratio; CI: Confidence interval; R2:
s less than 0.1 by an univariate analysis were entered into a multiple logistic
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Among patients who were not adherent to ART (n=63),
39 gave reasons for missed doses. Some of the most
common reasons were long distance to health facilities
(n = 21, 53.8%), food insufficiency (n = 20, 51.3%), being
busy with other activities such as work (n = 15, 38.5%),
being depressed (n = 5, 12.8%), and forgetfulness (n = 4,
10.3%) (Table 5).
Discussions
Status of ART adherence in the Mumbwa district
Based on a self-report, 59.9% were considered to be fully
adherent to ART six weeks after starting the treatment.
The adherence was lower than that found in studies con-
ducted in other countries in Sub-Saharan Africa, which
have shown a full medication adherence of 76% [27]. Al-
though a simple comparison is not accurate because of
large variation between the surveys, the difference could
be explained as follows.
First, it could be related to the different approach for
measuring ART adherence. As long-term viral suppres-
sion requires consistent and high level dose adherence
accompanied by optimal inter-dose intervals [28], ad-
herence to dose as well as adherence to schedule was
considered in this study. Those who never skipped pre-
scribed drugs and followed time restrictions during the
previous four days were considered to be fully adherent.
In contrast, most other studies that have measured ART
adherence using patient self-reporting have only looked
at adherence to dose instructions [27].
Second, possible difference in access to treatment
among patients who were in need for ART in Zambia
and other countries in Sub-Saharan Africa could also
have influenced the result. Nearly 70% of those in need for
treatment have accessed it in Zambia in both urban and
rural areas. On the other hand, studies in other AfricanTable 5 Reasons for missed doses (multiple answers)
(n=39)
n(%)
Long distance to health facilities 21 (53.8)
Not enough food 20 (51.3)
Were busy with other things like work etc. 15 (38.5)
Felt depressed, overwhelmed, hopelessness 5 (12.8)
Forgot 4 (10.3)
Felt sick or ill 3 (7.7)
Ran out of pills 2 (5.1)
Traditional prohibition 2 (5.1)
Felt asleep or slept through dose tine 1 (2.6)
Had a change in daily routine 1 (2.6)
Had problem taking pills at specific times with meals 1 (2.6)
Sold out the pills 1 (2.6)countries were conducted mostly in urban areas [27]
where patients have relatively easy access to health fa-
cilities. It could be expected that relatively high levels of
adherence in other studies may decline as treatment ac-
cess expands to rural area where people have poor access
to the health facility.Factors related to full adherence to ART
In a multivariate analysis, gender remained a significant
factor after adjusting for potential confounding variables.
In a study in rural Uganda, female patients had a signifi-
cantly higher CD4 cell count at the initiation of ART
and lower mortality six months later than male patients,
as female patients had more opportunities to access care
and start treatment at less advanced stages of HIV, po-
tentially through their participation in prevention of
mother-to-child transmission (PMTCT) programs [29].
In Zambia, PMTCT initiative was launched in 1999 and
expanded such that an estimated 69% of pregnant wo-
men living with HIV had received antiretroviral (ARV)
drugs for PMTCT by the end of 2009 [30]. As the case
of Uganda, national PMTCT services in Zambia may
have contributed to earlier access to ART and supported
better ART adherence for a larger group of HIV-positive
female, since early ART results in less AIDS progression
and death with no increase in adverse events or loss of
virologic response compared to deferred ART [31].
Although not determined in this study, sex differences
in treatment response and side effects could also have
contributed to the outcomes observed in this study.
Another study showed that female patients had better
responses to treatment compared with that of male pa-
tients, and side effects related to ARV drugs were more
frequently observed in male patients than in female pa-
tients [32].
Additionally, female patients may have had greater
motivation to adhere to ART as suggested by other study
that female patients caring for children emphasize their
role as primary care to children and their children are
known to be a facilitating factor in adherence among
them [33].
However, other studies have also shown that HIV-
positive females often experience gender-related barriers
to accessing health services, thus affecting ART adher-
ence [34,35]. For example, many females have to obtain
permission from a male spouse or a relative to seek HIV
care, which is difficult when females have to ask for mo-
ney and take time away from household chores. In ad-
dition, where costs for treatment are involved, families
may prioritize paying for male’s treatment [34]. Gender-
based violence has also affected female’s access and ART
adherence [36]. Although these barriers were not found
in this study, the issue demands further exploration,
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Regarding HIV disclosures, over 80% disclosed their
status to their spouse. This was positively associated
with treatment adherence in bivariate analysis, although
it was not seen in the final analysis. The spousal dis-
closure rate was relatively higher in this study than in a
study conducted in another part of rural Zambia in
2005–2006 [12]. The higher rate of disclosure in this
study may be attributed to the establishment of peer
counselors or treatment supporters during the past few
years in Zambia, which encourages disclosure and treat-
ment adherence in the district hospital and rural health
centers. However, disclosure could still have both po-
sitive and negative consequences. Disclosure has the
potential to yield much-needed social support. Alterna-
tively, it may also lead to stigmatization, discrimination,
abandonment or gender-based violence mentioned above
after disclosing their HIV status to their spouse or part-
ners. Strategies are needed to take account of HIV positive
patients who want to disclose HIV status safely to their
surroundings.
Having a treatment partner such as a spouse, family
member, friends or peer counselor is known to be posi-
tively associated with ART adherence [38]. In this study,
having a spouse who is also on ART was found to be
positively associated with ART adherence. Spouses on
ART might play a role as a treatment partner more read-
ily than spouses not on ART because they have a better
understanding of treatment adherence for their partners
and themselves. While it could not be determined from
the results whether spouses were supportive, ART pro-
grams should consider the potential benefit of treatment
support provided by persons close to patients, especially
from those on ART.
A number of qualitative studies have reported that
food insufficiency is an important barrier to ART ad-
herence [15,16,39,40]. In urban Peru, Franke et al. [26]
found that individuals who reported food insufficiency
in the month prior to interview were more likely to ex-
perience suboptimal adherence than those who did not.
In three rural ART clinics located in another part of
rural Zambia, patients who had skipped a meal because
of a lack of food in the past week were more likely to
have poor adherence [41].
However, on the contrary, this study found that the
experience of food insufficiency in the previous 30 days
from the baseline interview date was positively asso-
ciated with treatment adherence. This may be explained
by enhanced social support targeting people living in
such extreme poverty that they cannot afford to buy
food described as below. A pilot study in Zambia found
that individuals with food insufficiency who received nu-
tritional support demonstrated significantly better ARTadherence compared with a group who did not receive
this support [13]. The World Food Program (WFP) has
been implementing a program in Zambia since 1967 and
is committed to providing food assistance to approxi-
mately 2.3 million people in Zambia in 2011 [42]. Patients
who were extremely poor and suffered from insufficient
food at the initiation of ART might more easily receive
such assistance compared with patients who were not so
poor that they ever experienced food insufficiency at the
time, although it is difficult to rely only on such expla-
nation to account for everything since some donors have
suspended their assistance in Mumbwa.
On the other hand, one of the most cited reasons for
missing doses by this study population was also ‘food in-
sufficiency’, and the experience of food insufficiency in
the previous 30 days from the follow-up interview date
was also associated with poor treatment adherence by
bivariate analysis (data not shown). This paradoxical
finding could be understood by considering the timing
of the interviews. The question about reasons for miss-
ing doses was asked six weeks after starting ART, while
the positive association was found between treatment
adherence and the experience of food insufficiency in
the previous 30 days from the baseline interview date.
Therefore, patients who experienced food insufficiency
in the 30 days previous to ART initiation might have
received food supplementation or counseling afterwards,
which might have supported their adherence positively
as mentioned above. However, patients who were not so
poor thus they could not receive food assistance at the
initiation of ART might have needed financial assistance
after starting the treatment because of transportation fee
and loosing wages due to long waiting times for a clinic
visit. They might eventually have fallen into poverty and
food insecurity after starting ART, and could not adhere
to treatment, even if the ART services are provided free
of charge in Zambia.
Moreover, some patients may have been taught and
believed that ARV drugs always need to be taken with
food and some might have missed the medication as
they missed their meal due to the food insufficiency.
Thus, individuals who missed ARV drugs might consider
food insufficiency the reason. However, more studies are
needed to better understand the association between
ART adherence and food issues, because a single ques-
tion was used to assess food insufficiency in this study,
which is only one aspect of the issues.
In addition to ‘food insufficiency’, the frequently cited
reasons for missing doses in this study were ‘long dis-
tance to health facilities’ and ‘being busy with other things
like work’. This observation is consistent with findings in
other studies [16,18,27,39,43-54].
Although time required for transportation to the health
facilities and transportation fees were not significantly
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ment facilities can be a problem for many patients living
in Mumbwa. This is supported by the result that it took
over one hour to reach health facilities in half of patients
on ART in this study. Because of this long distance to ac-
cess to health facilities in Mumbwa, patients who missed
doses might report that the distance from home to the
district hospital or rural health centers caused the disrup-
tion in ART adherence.
In addition, patients whose occupation was agriculture
were more likely to have poor adherence. It is possible
that patients who worked in agriculture had difficulty
coming for health facilities because of their work’s sea-
sonal nature. This is probably supported by our finding
that ‘being busy with other things like work’ was the major
reason for missing doses.
To enhance understanding of self-stigma and depres-
sive symptoms among patients on ART in Zambia, the
associations between these psychological factors and treat-
ment adherence were assessed. Although these factors
have been identified as factors associated with poor adhe-
rence in multiple studies, no associations were found in
this study. The limited numbers of subjects with poor ad-
herence may have prevented the identification of potential
associations. More work is needed to investigate patients’
self-stigma and depressive symptoms with having to ad-
here to lifelong regimens.
Limitations
This study has several limitations. First, assessment of
treatment adherence based on a self-report may be sub-
ject to recall and social desirability bias that may result
in under-reporting of missed pill intakes. Thus, an over-
estimation of adherence is possible. However, there is
evidence that a simple self-report adherence question-
naire provides a sensitive measure of non-adherence that
predicts viral rebound and is almost always reliable
[55-57]. It is also an inexpensive and quick method to
use in a field research and resource poor setting.
Second, we could only include those individuals who
initiated ART at the target health facilities, and returned
six weeks later. Hence, we may also have slightly over-
estimated the actual adherence levels of this population,
and our sample may not be enough to detect significant
associations between patients who were adherent to
ART six weeks after starting the treatment and who were
not. However, this influence is likely to be limited be-
cause there were no significant differences in basic
sociodemographic or health characteristics between
patients who were included or excluded in this study ex-
cept for the required time to access health facilities
(Table 1).
Third, in relation to recent changes in Zambia, this
study was conducted in a rural area where ART serviceshave been initiated. Therefore, it is difficult to generalize
the study findings to the population in areas where ART
services are not yet available, although there were no dif-
ferences in patients’ characteristics between those who
visited the district hospital and rural health centers.
Future challenges
This study investigated patients’ adherence to ART over
a short period of time, because the initial response to
ART has long-term prognostic significance, and optimi-
zing adherence in the early months is important for en-
suring long-term immunological and virological success
[19,20]. However, long-term analyses are clearly needed
to fully assess factors related to treatment adherence and
to allow some generalizability of the results.
In addition, one of the most cited reasons for missing
doses was long distance to health facilities, and only dif-
ference in basic sociodemographic or health characteris-
tics between patients who were included and excluded
in this study was required time to access health facilities.
It is therefore necessary to examine the association bet-
ween travel-related variables and adherence to ART in
detail in future research, although they did not predict
the adherence in another study in rural Zambia [14].
Finally, recent changes such as the adoption of free ac-
cess to ART in Zambia may have some implications for
the study results. While it is expected that this policy
will reduce financial constraints, the high level of other
health expenditures still experienced by patients suggests
that the detrimental influence of out-of-pocket payments
will certainly not be fully eliminated. Further studies are
needed to assess and examine this policy for treatment
adherence and its interruptions over longer time scales.
Conclusions and recommendations
Social supports from spouses and people on ART could
facilitate their adherence to ART. This is likely to require
attention by ART services in the future, focusing on diffe-
rent social influences on male and female in rural Zambia.
In addition, poverty reduction strategies could help to
reinforce adherence to ART and mitigate the influence of
HIV infection for poor patients and those who fall into
poverty after starting ART.
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